Comparison Akari Therapeutics (AKTX) with Competitors
Akari Therapeutics (AKTX) industry is Biotechnology.
Free Cash Flow Yield
AKTX-6.52%
Industry-1.75%
Upside-4.77%
P/E
AKTX-8.66
Industry-20.52
Upside+1185.79%
P/S
AKTX478368.50
Industry10.01
Upside+4777119.28%
P/B
AKTX1.14
Industry5.15
Upside-77.83%